First trial of ‘base editing’ in humans lowers cholesterol — but raises safety concernsLee Duna@lemmy.nz to Science@beehaw.org – 40 points – 11 months agonature.com2Post a CommentPreviewHotTopNewOldCool picture. From what I gather they did not use a viral vector here? It mentions nanoparticles. I also wonder if there were any adverse affects among the animal tests too.Yeah looks like lipid nanoparticles.
Cool picture. From what I gather they did not use a viral vector here? It mentions nanoparticles. I also wonder if there were any adverse affects among the animal tests too.Yeah looks like lipid nanoparticles.
Cool picture. From what I gather they did not use a viral vector here? It mentions nanoparticles. I also wonder if there were any adverse affects among the animal tests too.
Yeah looks like lipid nanoparticles.